Virological breakthroughs during long-term Bulevirtide monotherapy in patients with CHD: integrated analysis from the multicenter real-life save-d and d-shield studies

Conference Reports for NATAP

EASL - European Association
for the Study of the Liver
Barcelona, Spain
May 27-30, 2026


Virological breakthroughs during long-term Bulevirtide monotherapy in patients with CHD: integrated analysis from the multicenter real-life save-d and d-shield studies

	EASL 2026 May 26-30 Barcelona E. Degasperi1,